Loading
Latest filing published 17 Mar 2026 for Rentokil Initial plc, €15k.
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Sally Johnson in Rentokil Initial plc. Between 31 July 2023 and 16 March 2026, the trades on record add up to 5 filings.
The open-market record is one-sided, with 5 purchases worth €68k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €14k. On 2 out of 5 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 5 purchases show a median change of +4.1%, with the price up in 60% of them. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 17 March 2026: an open-market purchase of €15k, in Rentokil Initial plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. For comparison, UK MAR gives managers three business days to notify a trade. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations